News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Cellceutix Announces Dr. Emil Frei to be On Its Scientific Advisory Board Through June 30, 2010
June 30, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BEVERLY, Mass., June 30, 2009 (GLOBE NEWSWIRE) -- Cellceutix Corporation (OTCBB:CTIX), announced today that Dr. Emil Frei has agreed to serve on the Cellceutix Scientific Advisory Board through June 30, 2010.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
IPO tracker
Generate Clocks Largest IPO Since 2024 With $400M Raise
February 27, 2026
·
5 min read
·
Tristan Manalac
Special edition
Deep Dive: BioSpace Takes On JPM26 in San Francisco
February 27, 2026
·
2 min read
·
Annalee Armstrong
Layoff Tracker
Viatris Will Cut Up to 10% of Global Workforce Over 3 Years
February 26, 2026
·
58 min read
·
BioSpace Editorial Staff
Deals
Boehringer Seeks To Rebalance Immunity With Sitryx Collab Potentially Worth $500M+
February 26, 2026
·
1 min read
·
Tristan Manalac